Related Experiment Videos
Buspirone therapy for maladaptive behavior and anxiety in developmentally disabled persons
J J Ratey1, R Sovner, E Mikkelsen
1Medifield State Hospital, Mass 02502.
The Journal of Clinical Psychiatry
|October 1, 1989
Summary
Buspirone effectively treated anxiety and behavioral issues in some individuals with developmental disabilities. This anxiolytic medication showed a favorable response in nine out of fourteen patients.
Area of Science:
- Psychopharmacology
- Developmental Disabilities
- Behavioral Science
Background:
- Anxiety, aggression, and self-injurious behaviors are common in individuals with developmental disabilities.
- Existing treatments for these behaviors may have significant side effects.
- Buspirone is an anxiolytic agent with a reported low side effect profile.